To support the tissue needs of the Projects, over the next five years, the Tissue Procurement Core will obtain a greater number of samples to be distributed among Program Project investigators. Not only will more samples be acquired, but each sample will be more intricately characterized by the clinical/symptomologic/familial traits of the donor. The Tissue Procurement Core will endeavor to increase the number of investigators performing studies on tissue from a solitary patient, so that the data collected will provide a complete profile of the patient, clinical and subclinical markers. The interactive Tissue Procurement data base has been established and data from the genetic and immunologic marker studies are being entered and cross analyzed. The team assigned to tissue procurement includes a procurement supervisor, a research studies coordinator, tissue procurement technician and data manager. The team has been working together for 9 months as of this writing and we are in an excellent position to provide more than adequate samples for the experiments proposed in this Program Project continuation application. The overall goal of the Tissue Procurement Core is to provide investigators with well-define samples, offer the ability to identify scientific and clinical trends using the interactive data base, and of course distribute serum, cells isolated from blood, mesenteric nodes, biopsies and surgical samples, and perform nucleic acid extractions as requested. The structure by which the Tissue Procurement Core provides this service is as follows: Tissue specimens are obtained for distribution to Program Project investigators for the purpose of research as described in their proposals. All tissue samples are matched with epidemiologic, and clinical characteristics, for easy correlation studies. Distribution of the samples is equal and adequate, based on need, ensuring that each investigator is provided with adequate samples to perform the experiments outlined in the proposal. Histopathological evaluation of human and rodent colitis samples is performed. Encourage use of samples from one donor by several investigators. Clinical data and results from basic science studies are coordinated to allow stratification of populations by a variety of clinical, subclinical, genetic and epidemiologic parameters.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Weiser, Matthew; Simon, Jeremy M; Kochar, Bharati et al. (2018) Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut 67:36-42
Seo, Goo-Young; Shui, Jr-Wen; Takahashi, Daisuke et al. (2018) LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection. Cell Host Microbe 24:249-260.e4
Clerc, Florent; Novokmet, Mislav; Dotz, Viktoria et al. (2018) Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases. Gastroenterology 155:829-843
Rivas, Manuel A; Avila, Brandon E; Koskela, Jukka et al. (2018) Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genet 14:e1007329
Hong, Myunghee; Ye, Byong Duk; Yang, Suk-Kyun et al. (2018) Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci. J Crohns Colitis 12:730-741
Freise, Amanda C; Zettlitz, Kirstin A; Salazar, Felix B et al. (2018) Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis. J Nucl Med 59:980-985
Šimurina, Mirna; de Haan, Noortje; Vu?kovi?, Frano et al. (2018) Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases. Gastroenterology 154:1320-1333.e10
Leonardi, Irina; Li, Xin; Semon, Alexa et al. (2018) CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. Science 359:232-236
Hui, Ken Y; Fernandez-Hernandez, Heriberto; Hu, Jianzhong et al. (2018) Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. Sci Transl Med 10:
Schwerd, T; Bryant, R V; Pandey, S et al. (2018) NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol 11:562-574

Showing the most recent 10 out of 277 publications